Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 25, 2006Antimicrobial Agents and ChemotherapyOpen Access

Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

AUAndrew J. UllmannDeutscher BundestagOCOliver A. CornelyUniversità Cattolica del Sacro CuoreABAlexander BurchardtJustus-Liebig-Universität Gießen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ullmann et al. (2006) studied this question.

synapsesocial.com/papers/6a21bde78d200acffec0ae3ehttps://doi.org/10.1128/aac.50.2.658-666.2006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species1997 · 759 citations
  2. 2In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. and Cryptococcus neoformans2001 · 144 citations
  3. 3Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus2002 · 2,347 citations
  4. 4Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients2001 · 364 citations
  5. 5Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi2003 · 371 citations